Stock HNSA HANSA BIOPHARMA AB
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Hansa Biopharma AB

Equities

HNSA

SE0002148817

Market Closed - Nasdaq Stockholm
Other stock markets
 11:59:36 08/05/2024 BST 		5-day change 1st Jan Change
30.62 SEK +5.22% Intraday chart for Hansa Biopharma AB +5.81% +16.87%
04-18 Transcript : Hansa Biopharma AB, Q1 2024 Earnings Call, Apr 18, 2024
04-18 Hansa Biopharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Hansa Biopharma Hires New CFO
MT
Hansa Biopharma Nomination Committee Formed
CI
Sweden's Hansa Biopharma CFO to Depart in February 2024
MT
Hahansa Biopharma AB Announces Resignation of Donato Spota as Chief Financial Officer, Effective 28 February 2024
CI
Sweden’s Hansa Biopharma Appoints New Chief Scientific Officer
MT
Hitto Kaufmann Appointed Chief Scientific Officer of Hansa Biopharma, Effective 1 December 2023
CI
Matthew Shaulis appointed Chief Commercial Officer and US President of Hansa Biopharma
AQ
Hansa Biopharma Names Former Pfizer Exec as Chief Commercial Officer
MT
Matthew Shaulis appointed Chief Commercial Officer and US President of Hansa Biopharma
AQ
Hansa Biopharma AB Appoints Matthew Shaulis as Chief Commercial Officer and US President of Hansa Biopharma
CI
Hansa Biopharma Chief Scientific Officer to Step Down in 2024
MT
Hansa Biopharma Announces Planned Departure of Chief Scientific Officer Christian Kjellman
CI
Correction Hansa Biopharma Nomination Committee formed
AQ
Correction: Hansa Biopharma Nomination Committee formed
AQ
Hansa Biopharma Nomination Committee formed - December 23, 2022
AQ
Hansa Biopharma Nomination Committee formed
AQ
Hansa Biopharma AB Announces Formation of Nomination Committee
CI
Hansa Biopharma AB Appoints Peter Nicklin as A New Member of the Board of Director
CI
Hansa Biopharma AB's Current Chair Ulf Wiinberg Has Chosen to Not Stand for Re-Election
CI
Hansa Biopharma AB Announces Ulf Wiinberg Not to Stand for Re-Election as Director
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HNSA Stock
  4. News Hansa Biopharma AB
  5. Insiders